NDUFB5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.798200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.939000E-01
Normal-vs-Stage2
7.013800E-01
Normal-vs-Stage3
3.112000E-01
Normal-vs-Stage4
6.771200E-01
Stage1-vs-Stage2
6.033400E-01
Stage1-vs-Stage3
2.747600E-01
Stage1-vs-Stage4
7.735800E-01
Stage2-vs-Stage3
2.001200E-01
Stage2-vs-Stage4
9.387200E-01
Stage3-vs-Stage4
3.547600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.528000E-01
Normal-vs-AfricanAmerican
7.160200E-01
Normal-vs-Asian
8.169200E-01
Caucasian-vs-AfricanAmerican
8.645000E-01
Caucasian-vs-Asian
6.361600E-01
AfricanAmerican-vs-Asian
8.534000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.682200E-01
Normal-vs-Female
7.151000E-01
Male-vs-Female
7.257400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.482300E-02
Normal-vs-Age(41-60Yrs)
8.808400E-01
Normal-vs-Age(61-80Yrs)
5.904200E-01
Normal-vs-Age(81-100Yrs)
8.353400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.681800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.186000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.129500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.194960E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.011800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.674030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.403000E-01
Normal-vs-Daily Drinker
3.899200E-01
Normal-vs-Weekly Drinker
2.332200E-01
Normal-vs-Occasional Drinker
9.225000E-01
Normal-vs-Social Drinker
6.502600E-01
Non Drinker-vs-Daily Drinker
6.516200E-01
Non Drinker-vs-Weekly Drinker
5.836600E-01
Non Drinker-vs-Occasional Drinker
1.747990E-01
Non Drinker-vs-Social Drinker
5.511600E-01
Daily Drinker-vs-Weekly Drinker
8.943400E-01
Daily Drinker-vs-Occasional Drinker
9.379800E-02
Daily Drinker-vs-Social Drinker
3.005200E-01
Weekly Drinker-vs-Occasional Drinker
8.866300E-02
Weekly Drinker-vs-Social Drinker
1.997010E-01
Occasional Drinker-vs-Social Drinker
4.386800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.882380E-01
Normal-vs-Grade 2
1.046360E-02
Normal-vs-Grade 3
1.878390E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.919320E-03
Grade 1-vs-Grade 3
1.852140E-02
Grade 1-vs-Grade 4
1.882380E-01
Grade 2-vs-Grade 3
6.022000E-01
Grade 2-vs-Grade 4
1.046360E-02
Grade 3-vs-Grade 4
1.878390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.751600E-01
Normal-vs-NonDiabetic
6.979800E-01
Diabetic-vs-NonDiabetic
3.225200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.731400E-01
Normal-vs-NoPancreatitis
6.877000E-01
Pancreatitis-vs-NoPancreatitis
8.360400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.772000E-01
Normal-vs-N1
6.930400E-01
N0-vs-N1
5.745000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.656200E-01
Normal-vs-TP53-NonMutant
6.078200E-01
TP53-Mutant-vs-TP53-NonMutant
2.134100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
